SIREN : 844325662
BIOXEGY GROUP is a French company founded 7 years ago, specialized in the sector Gestion de fonds. Based in PUTEAUX (92800), this company of category PME shows in 2024 a revenue of 213 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 212 811 € | 50 184 € | 48 930 € | 48 677 € | 42 633 € | 33 482 € |
| Net income | 5 168 € | 26 146 € | 11 358 € | 28 710 € | 31 942 € | 6 915 € |
| EBITDA | 6 696 € | -125 027 € | -40 567 € | -16 970 € | 13 169 € | 3 906 € |
| Net margin | 2.4% | 52.1% | 23.2% | 59.0% | 74.9% | 20.7% |
In 2024, BIOXEGY GROUP achieves revenue of 213 k€. Over the period 2019-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +44.8%. Vs 2023, growth of +324% (50 k€ -> 213 k€). After deducting consumption (10 k€), gross margin stands at 203 k€, i.e. a rate of 95%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 7 k€, representing 3.1% of revenue. Positive scissor effect: EBITDA margin improves by +252.3 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 5 k€, i.e. 2.4% of revenue. This profit can be retained or distributed to shareholders.
212 811 €
202 677 €
6 696 €
6 114 €
5 168 €
3.1%
The debt ratio (= Financial debt / Equity x 100) stands at 46%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 9.9 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 2.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
45.704%
43.204%
2.713%
9.914
In 2024, the debt ratio of BIOXEGY GROUP (45.70) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of BIOXEGY GROUP (43.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of BIOXEGY GROUP (9.91) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 0.00. Alert: short-term debt exceeds current assets. Risk of payment difficulties without cash reinforcement. The interest coverage ratio (= EBIT / Interest expenses) is 0.5x. Danger: operating income does not cover interest charges, unsustainable situation.
0.0
0.493
In 2024, the liquidity ratio of BIOXEGY GROUP (0.00) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of BIOXEGY GROUP (0.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 18 days. Favorable situation: supplier credit is longer than customer credit by 18 days. WCR is negative (-181 days): operations structurally generate cash. Notable WCR improvement over the period (-6613%), freeing up cash.
-106 882 €
0 j
18 j
0 j
-181 j
Based on 62 transactions of similar company sales
in 2024,
the value of BIOXEGY GROUP is estimated at
43 137 €
(range 17 220€ - 105 409€).
With an EBITDA of 6 696€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOXEGY GROUP with other companies in the same sector:
The revenue of BIOXEGY GROUP in 2024 is 213 k€.
Yes, BIOXEGY GROUP generated a net profit of 5 k€ in 2024.
The headquarters of BIOXEGY GROUP is located in PUTEAUX (92800), in the department Hauts-de-Seine.
The tax return of BIOXEGY GROUP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOXEGY GROUP operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.